Dabur India Limited appoints Dr. Anand Chand Burman as Director

The Board of Directors of Dabur India Limited has, in its meeting held today i.e. on March 25, 2022, based on the recommendation of Nomination and Remuneration Committee, appointed Dr. Anand Chand Burman (DIN: 00056216) as an alternate director to Mr. Amit Burman, NonExecutive Director, w.e.f. March 25, 2022.

Dr. Anand C. Burman is the honorary advisor to the Board of Dabur India Ltd, one of India's leading consumer goods companies with presence in over 100 countries across the globe. Dr. Burman is a trained pharmacist and is widely recognized for his interests in Research & Development that has helped him earn over 40 patents in his name.

Dr. Burman has particular interests in the areas of R&D in Pharmaceutical Sciences as well as Biotechnology and Technology issues. His education was both multidisciplinary and international. He completed his high school education from St. Paul's School in Darjeeling, India and followed it with a B.Sc. in Chemistry from the University of Wisconsin and M.Sc. in Chemistry from the University of Kansas. His Doctorate was in the area of Pharmaceutical Chemistry from the University of Kansas in 1980.

Dr. Burman is a member of the fifth generation of Dabur group's founder family and took charge as the Chairman of Dabur India Ltd. in 2007 after holding the post ofVicechairman and having been associated with the company in various other roles. His interests in R&D closely align with Dabur's focus on developing products that offer holistic wellness, and spearheaded Dabur's transformation from an Ayurvedic medicines maker to becoming India's 4th largest FMCG (Fast Moving Consumer Goods) player. He also serves as Director on the Board of Dabur International Ltd., Dabur Research Foundation, Dabur (UK) Ltd., H&B Stores Ltd., among others. He stepped down as the Chairman of Dabur India Ltd. in 2019.

Other than the Dabur Group Companies, he is also on the Board of Aviva Life Insurance, Ester Industries Limited, etc. In addition, he is a member of the Advisory Board of the Institute for Advancing Medical Innovation under the University of Kansas, USA.

Dr. Burman is the recipient of numerous awards and honors, including the Ernst & Young Entrepreneur Of The Year award in 2011.

Shares of Dabur India Limited was last trading in BSE at Rs. 519.85 as compared to the previous close of Rs. 523.80. The total number of shares traded during the day was 154367 in over 5795 trades.

The stock hit an intraday high of Rs. 527.00 and intraday low of 518.00. The net turnover during the day was Rs. 80834335.00.

Source : Equity Bulls

Keywords

DaburIndia INE016A01026 Appointment DrAnandChandBurman